Physician profile
Susan Probst
NPI 1538197348
$3,005.90
in general payments reported to CMS, 2019-2025
23 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $490 · 2020: $222 · 2021: $363 · 2022: $596 · 2023: $566 · 2024: $484 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,296 · Debt Forgiveness: $38.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,296.47 |
| Debt Forgiveness | $38.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $878.26 | 2019-2023 | |
| Astellas Pharma US INC | $525.19 | 2022-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $374.69 | 2021-2025 | |
| Novo Nordisk INC | $342.44 | 2020-2025 | Wegovy |
| Therapeuticsmd, INC. | $138.51 | 2019-2021 | |
| Pfizer INC. | $81.69 | 2020-2023 | |
| Axonics, INC. | $77.57 | 2021 | |
| Sumitomo Pharma America, INC. | $75.86 | 2024-2025 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $73.93 | 2024-2025 | Slynd |
| Coopersurgical, INC. | $54.21 | 2022-2024 | Paragard T 380a |
| Acessa Health INC. | $47.29 | 2019 | |
| Bluewind Medical | $46.39 | 2024 | Revi |
| Exact Sciences Corporation | $42.96 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Organon LLC | $41.89 | 2024-2025 | Nexplanon |
| Baxter Healthcare | $38.71 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $30.46 | 2023 | Seglentis |
| Hologic Sales and Service, LLC | $29.98 | 2020-2022 | |
| Avion Pharmaceuticals | $29.80 | 2019-2022 | |
| Covidien LP | $18.53 | 2019 | |
| Amgen INC. | $16.92 | 2023 | Prolia, Evenity |
| Amag Pharmaceuticals, INC. | $15.04 | 2020 | |
| Acelrx Pharmaceuticals, INC. | $12.83 | 2022 | |
| Minerva Surgical, INC | $12.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Probst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.